Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cheadle

Showing results (61-70 of 79) with videos related to

Pageof 8
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2017
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian CancerGemma L Owens, Victoria E Sheard, Milena Kalaitsidou, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Chimeric antigen receptors for T-cell based therapyEleanor J Cheadle, Vicky Sheard, Andreas A Hombach, et al.
Human Molecular Genetics|June 13, 1998
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene productsM van Slegtenhorst, M Nellist, B Nagelkerken, et al.
Frontiers in Cell and Developmental Biology|November 29, 2023
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignanciesEster Fagnano, Swati Pendharkar, Madyson Colton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJ F Seligmann, D Fisher, C G Smith, et al.
Oncology Research|March 9, 2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD StudyShuhui Cheng, Tiana Kordbacheh, Antonia Banyard, et al.
Communications Medicine|April 1, 2026
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicityHanan Abumanhal-Masarweh, Salam A Assi, Xinming Liu, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2013
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trialRyan D Guest, Natalia Kirillova, Sam Mowbray, et al.
Blood|March 8, 2011
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignanciesWaleed Alduaij, Andrei Ivanov, Jamie Honeychurch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Pageof 8

Showing results (61-70 of 79) with videos related to

Sort By:
Pageof 8
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 15, 2017
Preclinical Assessment of CAR T-Cell Therapy Targeting the Tumor Antigen 5T4 in Ovarian CancerGemma L Owens, Victoria E Sheard, Milena Kalaitsidou, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2012
Chimeric antigen receptors for T-cell based therapyEleanor J Cheadle, Vicky Sheard, Andreas A Hombach, et al.
Human Molecular Genetics|June 13, 1998
Interaction between hamartin and tuberin, the TSC1 and TSC2 gene productsM van Slegtenhorst, M Nellist, B Nagelkerken, et al.
Frontiers in Cell and Developmental Biology|November 29, 2023
Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignanciesEster Fagnano, Swati Pendharkar, Madyson Colton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: analysis from 2530 patients in randomised clinical trialsJ F Seligmann, D Fisher, C G Smith, et al.
Oncology Research|March 9, 2026
Investigating the Immune Effects of Radiotherapy in Non-Small Cell Lung Cancer-Results of the PD-RAD StudyShuhui Cheng, Tiana Kordbacheh, Antonia Banyard, et al.
Communications Medicine|April 1, 2026
Longitudinal plasma nano-proteomics reveals acute systemic responses to radiotherapy and predictive biomarkers of late toxicityHanan Abumanhal-Masarweh, Salam A Assi, Xinming Liu, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2013
Definition and application of good manufacturing process-compliant production of CEA-specific chimeric antigen receptor expressing T-cells for phase I/II clinical trialRyan D Guest, Natalia Kirillova, Sam Mowbray, et al.
Blood|March 8, 2011
Novel type II anti-CD20 monoclonal antibody (GA101) evokes homotypic adhesion and actin-dependent, lysosome-mediated cell death in B-cell malignanciesWaleed Alduaij, Andrei Ivanov, Jamie Honeychurch, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 20, 2005
The role of extracellular spacer regions in the optimal design of chimeric immune receptors: evaluation of four different scFvs and antigensRyan D Guest, Robert E Hawkins, Natalia Kirillova, et al.
Pageof 8